Old Web
English
Sign In
Acemap
>
authorDetail
>
Lory Molino
Lory Molino
Johnson & Johnson Pharmaceutical Research and Development
Pharmacology
Topiramate
Medicine
Neuropathic pain
δ-opioid receptor
3
Papers
110
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
JNJ-20788560 [9-(8-Azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic Acid Diethylamide], a Selective Delta Opioid Receptor Agonist, Is a Potent and Efficacious Antihyperalgesic Agent That Does Not Produce Respiratory Depression, Pharmacologic Tolerance, or Physical Dependence
2009
Journal of Pharmacology and Experimental Therapeutics
Ellen E. Codd
John R. Carson
Raymond W. Colburn
Dennis J. Stone
Christopher R. Van Besien
Sui-Po Zhang
Paul R. Wade
Elizabeth L. Gallantine
Theo F. Meert
Lory Molino
Shirley Pullan
Christine M. Razler
Scott L. Dax
Christopher M. Flores
Show All
Source
Cite
Save
Citations (59)
Tramadol and several anticonvulsants synergize in attenuating nerve injury-induced allodynia
2008
Pain
Ellen E. Codd
Rebecca P. Martinez
Lory Molino
Kathryn E. Rogers
Dennis J. Stone
Ronald J. Tallarida
Show All
Source
Cite
Save
Citations (34)
The Novel Anticonvulsant Topiramate is Antiallodynic in a Rat Model of Neuropathic Pain
1999
Annette M. Shadiack
Lory Molino
Susan K. Yagel
Richard P. Shank
Kathryn E. Rogers
Ellen E. Codd
Richard B. Raffa
Kenneth D. Wild
Show All
Source
Cite
Save
Citations (17)
1